Intuitive Surgical, Inc. $ISRG Stock Position Boosted by Vantage Investment Partners LLC

Key Points

• Vantage Investment Partners increased its Intuitive Surgical position by 464.2% in the third quarter, bringing its holdings to 90,825 shares worth approximately $36.9 million. Institutional investors collectively own 83.64% of ISRG.
• Intuitive Surgical reported strong quarterly results, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share, beating analysts’ estimates of $2.91 billion and $2.65, respectively.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $493.54, though insider selling and concerns about margin pressure remain potential risks for the premium-valued stock.

Vantage Investment Partners LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 464.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 90,825 shares of the medical equipment provider's stock after purchasing an additional 74,727 shares during the quarter. Intuitive Surgical comprises about 2.2% of Vantage Investment Partners LLC's holdings, making the stock its 17th biggest holding. Vantage Investment Partners LLC's holdings in Intuitive Surgical were worth $36,932,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Beaumont Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.8% in the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider's stock worth $255,000 after buying an additional 23 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its position in shares of Intuitive Surgical by 1.0% during the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider's stock valued at $1,172,000 after acquiring an additional 25 shares in the last quarter. Blue Fin Capital Inc. increased its position in shares of Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider's stock valued at $2,210,000 after acquiring an additional 25 shares in the last quarter. Red Spruce Capital LLC increased its position in shares of Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider's stock valued at $255,000 after acquiring an additional 25 shares in the last quarter. Finally, Worthington Financial Partners LLC raised its holdings in Intuitive Surgical by 1.3% in the 3rd quarter. Worthington Financial Partners LLC now owns 1,885 shares of the medical equipment provider's stock worth $767,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on ISRG shares. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Wednesday, October 21st. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $575.00 to $550.00 and set an "outperform" rating for the company in a report on Wednesday, October 21st. Barclays restated an "overweight" rating and issued a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BTIG Research restated a "buy" rating and issued a $454.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, Stifel Nicolaus lowered their price target on Intuitive Surgical from $670.00 to $550.00 and set a "buy" rating on the stock in a report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $493.54.

Intuitive Surgical Stock Down 0.4%

ISRG opened at $444.18 on Thursday. The firm has a 50 day moving average price of $399.37 and a 200-day moving average price of $435.44. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock has a market capitalization of $153.97 billion, a price-to-earnings ratio of 53.71, a PEG ratio of 3.12 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts' consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the firm earned $2.40 earnings per share. The firm's revenue for the quarter was up 21.7% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia Wadors sold 1,078 shares of the stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the firm's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 38,806 shares of company stock worth $16,824,795. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.